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A B S T R A C T
The aim of our paper was to investigate the influence of the different morphological changes on gastric mucosa on
somatostatin D-cell number in antral mucosa and serum Somatostatin. We analyzed according to Sydney classification
to what extent the severity of gastritis affect the observed hormonal values. somatostatin D-cell number in antral mucosa
and serum Somatostatin values were compared between three grups of patients; mild, moderate and severe cronic gastri-
tis. The average number of somatostatin cell in biopsy sample of antrum mucosa was 30.41±35.38 (N=17) in the case of
middle form, 18.69±26.65 (N=56) in moderate and in severe case of chronic gastritis 5.23±5.93 (N=7) cells in mm² of
mucosa. The level of somatostatin in the serum of middle form gastritis were 26.43±28.76, moderate 19.95±35.93 and se-
vere 17.88±17.66 pg/mL. In order to determine the number of somatostatin cells in antrum mucosa and serum somato-
statin with present morphological changes of mucosa, it might helpful to exclude the patients with non-ulcer dyspepsia,
but with the higher risk of premalignant and malignant changes.
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Introduction
Somatostatin is a hormone significantly participating
in regulation of stomach secretion1. Released somato-
statin in antrum mucosa has an inhibitory influence on
gastric cells, preventing the gastric acid secretion2,3. Chro-
nic gastritis is as well characterized by inflammatory cell
infiltration of lamina propria, accompanied by atrophy of
glandular epithelium4,5. Initially, the reaction is rather
superficial, but an intense inflammation might infiltrate
the whole mucosa causing the development of chronic at-
rophy gastritis6–8. This type of gastritis can provoke
metaplastic changes which are associated with occur-
rence of intestinal stomach carcinoma9,10. Therefore, we
investigated influence of pathological changes, like dif-
ferent gastritis types, and different morphological chan-
ges on the number of somatostatin D-cells in stomach
antrum, and serum somatostatin.
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Subjects and Methods
Subjects
The study includes 80 patients underwent endosco-
pies due to dyspeptic problems like: epigastric pain, heart-
burn, nausea and vomiting. The patients with acute and
chronic organic disease, as well as those taking antibiot-
ics, inhibitory protonic pump or inhibitory histaminic re-
ceptor drugs in the last month were excluded.
Endoscopy and biopsy
The endoscopic examination included the bioptic sam-
ples, taken on an empty stomach without premedication.
The total number of 4 bioptic samples were taken, 1 from
the side of the antrum greater curvature and 1 from the
side of antrum lesser curvature 2 cm from pylorus, 1
from the side of body of the stomach greater curvature
and 1 from the side of body of the stomach lesser curva-
ture for coloring according to Giemsa.
The number of somatostatin D-cells
In order to determine number of somatostatin cells in
stomach mucosa, we have used biopsy sample of greater
curvature of antrum, taken 1 cm from pylori and the re-
sult has been expressed as the number of cells in mus-
coulous mucosa millimeter. The histological material was
treated with ANTI-SOMATOSTATIN, Dako LSAB kit
(CODE NO. N 1551). The primary antibody was 7 mL of
rabbit antiserum on somatostatin in 0,05 M Tris pufern
pH 7.6. The further methods of sample analysis strictly
followed the producer’s guidelines (DACO). The cells
were counted using computer program for automatic pic-
ture processing, VANS, Zagreb Applications form11. First
of all, we have measured the sample surface and then
counted the somatostatin cells, in order to obtain an ex-
act number of somatostatin cells in mm2 of antrum mu-
cosa. The cells were counted in two samples and pre-
sented as an average number of cells for both samples.
Radioimmunoassay of serum somatostatin
In the assay procedure we used a protocol which is
similar to previously described by Arimura et al.11. This
kit is standardized with Synthetic Somatostatin (SS-14),
(INCSTAR Corporation-Stillwater, Minessota, USA).
Statistics
We have used Mann-Whitney U-test (Wicoxon Scores),
Medijan test for independent samples, Kruskal-Wallis
test and Komogor-Smirna test, whereas we have applied
Savage Scope test for analysis of homogeneity. The statis-
tical data analysis was done according to the program
packages of SAS (SAS Institute) and Mathematical (Wol-
fran Research).
Ethical considerations
All patients have signed written consent to our study.
The study was approved by the Ethics Committee of the
Internal Clinic, »J. J. Strossmayer« University.
Results
Applying Sydney classification, patients with chronic
gastritis were divided in three types; mild moderate and
severe case. The average number of somatostatin cell in
biopsy sample of antrummucosa was 30.41±35.38 (N=17)
in the case of mild form, 18.69±26.65 (N=56) in moder-
ate and in severe case of chronic gastritis 5.23±5.93
(N=7) cells in mm2 of mucosa (Figure 1). The results
show that the number of somatostatin cells in biopsy
sample significantly decreases depending on the severity
of gastritis type (p<0.05). The diffuse gastritis type had
66 patients (84.62%) and antral type 12 (15.38%). The
average number of somatostatin cells in biopsy sample of
stomach antrum in the case of diffuse gastritis type was
17.95±25.19 and in the antral type 32.88±41.83 cells in
mm2 (Figure 2). There is a statistically significant in-
crease of somatostatin cells in antraltype in comparison
to diffuse type (p<0.05). The level of somatostatin in the
serum of middle form gastritis were 26.43±28.76, moder-
ate 19.95±35.93 and severe 17.88±17.66 pg/mL (Figure
3). The results show that value of serum somatostatin
significantly decreases depending on the severity of in-
flammation. The occurrence of intestinal metaplasia and
atrophy of stomach mucosa as a consequence of the se-
S. Mihaljevi} et al.: Changes on Gastric Mucosa on Somatostatin Cell Number, Coll. Antropol. 35 (2011) 1: 5–8
6
Fig. 1. Histogram of somatostatin cells in stomach mucosa ac-
cording to gastritis grade.
Fig. 2. Histogram of somatostatin cells in mucosa according to
gastritis type.
verity of gastritis type were tightly monitored. Two pa-
tients (11.8%) with a mild gastritis type, had atrophy of
stomach mucosa, but not intestinal metaplasia. However,
11 patients (19.3%) suffering from moderate gastritis
type had atrophy of stomach mucosa and 5 had intestinal
metaplasia. In the case of severe gastritis type, 7 (100%)
patients had atrophy of stomach mucosa and 5 (71%) in-
testinal metaplasia. The results suggest a significant ten-
dency of intestinal metaplasia and atrophy of stomach
mucosa depending on the type of gastritis.
Discussion
The gastric acid has an extremely aggressive influ-
ence on stomach mucosa, what was recognized at the be-
ginning of the last century and therefore so many studies
have done pathophisiological analysis of stomach secre-
tion disorders13–15. Analyzing numerous studies, Calam
has concluded that gastric G-cells are under the constant
control, actually suppressed by somatostatin D-cells of
antrum mucosa and its special products16–18. Several
studies have analyzed alteration of antrum somatostatin
D-cell number depending on endscopically visible chan-
ges like: erosion, tumor or ulcers19–21. Our study is fo-
cused on the changes occurring among the patients with
dyspepsia. Applying Sydney classification22 of chronic
gastritis, we have inestigated influence of the grade and
the type of gastritis on somatostatin cell number of stom-
ach antrum and serum somatostatin. The results indi-
cate a strong impact of gastritis severity on somatostatin
cell number in antrum. The similar results were ob-
tained by Konturek and Bjelanski23. The chronic inflam-
mation of stomach mucosa reduces the number of so-
matostatin cells and serum somatostatin values, but
increases serum gastrin value and stimulates stomach
acid secretion24. Furthermore, we would have an in-
crease of intestinal metaplasia and stomach mucosa atro-
phy, as described by Sipponen and Kuipers25,26. There-
fore, preventing the deterioration of gastritis type is very
important as well as early detection and prevention of
potential premalignant changes4,5,9,10,27. The number of
somatostatin cells in antrum mucosa in diffuse gastritis
type28,29 is much smaller than in antral gastritis type,
what can be explained with the fact that antral gastritis
is milder type in comparison to diffuse type which infil-
trates bigger surface, provoking bigger pathophisiolo-
gical changes. In order to determine the number of
somatostatin cells in antrum mucosa with present mor-
phological mucosal changes, it might be helpful to ex-
clude the patients with non-ulcer dyspepsia, but with the
higher risk of premalignant and malignant changes.
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Fig. 3. Histogram of serum somatostatin according to gastritis
grade.
UTJECAJ RAZLI^ITIH MORFOLO[KIH PROMJENA @ELU^ANE SLUZNICE NA BROJ
SOMATOSTATINSKIH STANICA U SLUZNICI ANTRUMA @ELUCA I VRIJEDNOSTI
SOMATOSTATINA U SERUMU
S A @ E T A K
U ovom radu istra`ili smo utjecaj razli~itih morfolo{kih promjena `elu~ane sluznice na broj somatostatinskih D
stanica sluznice antruma `eluca i serumski somatostatin. Prema Sydnejskoj klasifikaciji gastritisa analizirali smo koli-
ko ja~ina upalnih promjena sluznice `eluca utje~e na promatrane vrijednosti hormona. Broj somatostatinskih D stanica
u sluznici antruma `eluca i vrijednosti serumskog somatostatina uspore|ivali smo kod tri grupe pacijenata: s blagim,
umjerenim i te{kim kroni~nim gastritisom. Prosje~ni broj somatostatinskih stanica u biopti~kom uzorku sluznice an-
truma bio je 30,41±35,38 (N=17) u blagom gastritisu, 18,69±26,65 (N=56) u umjereno te{kom i 5,23±5,93 (N=7) stanica
u mm2 sluznice. Vrijednosti serumskog somatostatina u blagom gastritisu bile su 26,43±28,76, umjerenom 19,95±35,93
i te{kom obliku 17,88±17,66 pg/mL. Odre|ivanje broja somatostatinskih stanica sluznice antruma `eluca i serumskog
somatostatina kod odre|enih morfolo{kih promjena `elu~ane sluznice mo`e nam pomo}i da izdvojimo pacijente s neul-
kusnom dispepsiom te one koji imaju veliki rizik od razvoja premalignih i malignih promjena.
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